1.
Humani TS, Sutari S, Triningsih T, Ramli M, Ritawidya R, Haryuni RD. Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancers Treatment. J. Math. Fund. Sci. [Internet]. 2017Dec.13 [cited 2025Nov.1];49(3):258-6. Available from: https://journals.itb.ac.id/index.php/jmfs/article/view/2375